You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nonazotemic patients with cirrhosis and moderate ascites

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

SGLT-2 Inhibitors in the Treatment of Ascites

Recruiting
  • Ascites Hepatic
  • +2 more
  • SGLT2 inhibitor
  • Palermo, Italy
  • +1 more
Aug 11, 2023

Ascites Trial in Houston (Albumin)

Recruiting
  • Ascites
  • Houston, Texas
    Baylor St' Lukes Medical center
May 10, 2023

Acute-On-Chronic Liver Failure In Cirrhotic Patients

Completed
  • Cirrhosis, Liver
    • Sohag, Egypt
      Sohag University
    May 12, 2022

    Portal Hypertension Trial in Nanjing (Endoscopy+NSBBs, Transjugular intrahepatic portosystemic shunt)

    Recruiting
    • Portal Hypertension
    • Endoscopy+NSBBs
    • Transjugular intrahepatic portosystemic shunt
    • Nanjing, Jiangsu, China
      Nanjing Drum Tower Hospital
    Aug 22, 2023

    Liver Cirrhosis Trial in Bunkyo-Ku (Foscenvivint)

    Not yet recruiting
    • Liver Cirrhosis
    • Bunkyo-Ku, Tokyo, Japan
      Tokyo Metropolitan Komagome Hospital
    Nov 29, 2023

    Cirrhosis, Liver Failure Trial (Empagliflozin 10 MG, Matching Placebo)

    Not yet recruiting
    • Cirrhosis
    • Liver Failure
    • Empagliflozin 10 MG
    • Matching Placebo
    • (no location specified)
    Feb 2, 2023

    Liver Cirrhosis Trial in Sohag (stool analysis)

    Not yet recruiting
    • Liver Cirrhosis
    • stool analysis
    • Sohag, Egypt
      Sohag university hospital
    May 3, 2023

    NAFLD Cirrhosis Trial in New Delhi (Dapagliflozin, Standard of Care)

    Not yet recruiting
    • NAFLD Cirrhosis
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences
    May 5, 2023

    Acute-On-Chronic Liver Failure, Ascites Trial (VS-01 on top of SOC, SOC (Control Group))

    Not yet recruiting
    • Acute-On-Chronic Liver Failure
    • Ascites
    • VS-01 on top of SOC
    • SOC (Control Group)
    • (no location specified)
    Jun 2, 2023

    Portal Hypertension, Gastric Varices Bleeding, Portosystemic Shunt Trial (preemptive TIPS, standard second prophylaxis)

    Not yet recruiting
    • Portal Hypertension
    • +2 more
    • preemptive TIPS
    • standard second prophylaxis
    • (no location specified)
    Nov 3, 2023

    Point-of-Care Echocardiography to Assess Impact of Dynamic

    Recruiting
    • Cirrhosis, Liver
    • +4 more
    • Echocardiographic assessment
    • Chandigarh, Delhi, India
      PGIMER
    Jan 17, 2023

    QOL and Sarcopenia in Patients With Ascites

    Not yet recruiting
    • Ascites Hepatic
    • Ascites, Malignant
    • Quality of Life surveys
    • Philadelphia, Pennsylvania
      University of Pennsylvania Perelman School of Medicine
    Feb 10, 2023

    Liver Cirrhosis Trial in New Delhi (drug, biological, other)

    Not yet recruiting
    • Liver Cirrhosis
    • New Delhi, Delhi, India
      Institute of Liver & Biliary Sciences (ILBS)
    Oct 13, 2023

    Sarcopenia and Myosteatosis in Cirrhotic Patients and to Study

    Recruiting
    • Cirrhosis
      • Hyderabad, Telangana, India
        Asian Institute of Gastroenterology/AIG Hospitals
      Dec 11, 2021

      Liver Cirrhosis, Cirrhosis, Ascites Trial in Redwood City (Empagliflozin 10 MG)

      Recruiting
      • Liver Cirrhosis
      • +4 more
      • Empagliflozin 10 MG
      • Redwood City, California
        Stanford University Digestive Health Clinic
      Mar 21, 2022

      Application of NGS in Ascites Infection

      Recruiting
      • Ascites Infection
      • Liver Diseases
      • Next generation sequence
      • Chongqing, Chongqing, China
        The Second Affiliated Hospital of Chongqing Medical University
      Aug 8, 2022

      Liver Cirrhosis, Liver Trial (Sequential Adult Left Lateral Liver Transplantation)

      Not yet recruiting
      • Liver Cirrhosis
      • Liver
      • Sequential Adult Left Lateral Liver Transplantation
      • (no location specified)
      Nov 22, 2023

      Liver Failure, Acute on Chronic, Hepatic Encephalopathy, HBV Trial in Guangzhou (Rifaximin 200 mg, Standard Treatment without

      Recruiting
      • Liver Failure, Acute on Chronic
      • +5 more
      • Rifaximin 200 mg
      • Standard Treatment without Rifaximin
      • Guangzhou, Guangdong, China
        The Third Affiliated Hospital of Sun Yat-sen University
      Mar 26, 2023

      Ascites Hepatic Trial in Alexandria (Empagliflozin 10 MG, Diuretics)

      Recruiting
      • Ascites Hepatic
      • Alexandria, Egypt
        Alexandria University
      Jun 18, 2022

      Hepatic Encephalopathy Trial in New Orleans (Rifaximin SSD, Placebo)

      Recruiting
      • Hepatic Encephalopathy
      • Rifaximin SSD
      • Placebo
      • New Orleans, Louisiana
        Bausch Site 501
      Aug 16, 2022

      Liver Cirrhosis Trial in New Delhi (Tolvaptan Tablets, Midodrine Oral Tablet, Placebo)

      Recruiting
      • Liver Cirrhosis
      • Tolvaptan Tablets
      • +2 more
      • New Delhi, Delhi, India
        Institute of Liver & Biliary Sciences
      Nov 24, 2021

      Changes of Ceftriaxone in Patients With Liver Cirrhosis

      Recruiting
      • Antibiotic Toxicity
      • +5 more
      • No intervention
      • Amsterdam, Netherlands
        Amsterdam university medical centers location AMC
      Jul 21, 2023

      Alpha-1 Antitrypsin Deficiency Trial in San Diego, Boston, Saint Louis (Liver Biopsy (Biopsy Group Only))

      Recruiting
      • Alpha-1 Antitrypsin Deficiency
      • Liver Biopsy (Biopsy Group Only)
      • San Diego, California
      • +2 more
      Dec 13, 2022

      Cirrhosis, Ascites, Hepatorenal Syndrome Trial in United States (OCE-205, Placebo)

      Recruiting
      • Cirrhosis
      • +3 more
      • San Francisco, California
      • +6 more
      Aug 3, 2022

      Nonalcoholic Steatohepatitis With Advanced Fibrosis

      Recruiting
      • Nonalcoholic Steatohepatitis
      • Standard of care
      • Richmond, Virginia
        Virginia Commonwealth University
      Jan 31, 2023